Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02498821 · ClinicalTrials.gov registry record · NA
Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation
A NA study of Indication for PICC Placement, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 4
- Study locations
NCT02498821 is a NA study of Indication for PICC Placement that has completed, run by C. R. Bard. The registered enrollment target is 120 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT02498821, a NA study of Indication for PICC Placement, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the study is to evaluate differences in the time and costs between Sherlock 3CG® TCS and Chest X-ray to confirm the location of a Peripherally Inserted Central Catheter (PICC).
Conditions Studied
Interventions
- DEVICE Chest X-ray
- DEVICE Sherlock 3CG® TCS
- PROCEDURE Peripherally Inserted Central Catheter (PICC)
Study Locations (4)
Maryland
- University of Maryland - Baltimore - Baltimore
- Peninsula Regional Medical Center - Salisbury
Florida
- Florida Hospital - Maitland
New York
- Unity Hospital - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02498821
The ClinicalTrials.gov registry entry for NCT02498821 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Indication for PICC Placement appearing as the primary indexed condition, and to 3 interventions - of which Chest X-ray is the first listed.
NCT02498821 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Maryland, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT02498821 about?
NCT02498821 is a clinical study titled "Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation". The purpose of the study is to evaluate differences in the time and costs between Sherlock 3CG® TCS and Chest X-ray to confirm the location of a Peripherally Inserted Central Catheter (PICC).
What is the current status of trial NCT02498821?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2015-05. Estimated completion is 2016-05.
What conditions does trial NCT02498821 study?
This clinical trial studies the following conditions: Indication for PICC Placement.
What interventions are being tested in trial NCT02498821?
The interventions under investigation include: Chest X-ray (DEVICE), Sherlock 3CG® TCS (DEVICE), Peripherally Inserted Central Catheter (PICC) (PROCEDURE).
Who is sponsoring clinical trial NCT02498821?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02498821 being conducted?
This trial has 4 study locations across Florida, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.